Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
JW

Jean-Charles Wirth

Executive Board Member and Life Science CEO, Merck KGaA

Appears in 1 story

Notable Quotes

"This transaction strengthens our presence in some of the most exciting areas of life sciences." — Jean-Charles Wirth

Stories

Merck KGaA buys Bio-Techne in its biggest deal since 2015

Money Moves

Will absorb Bio-Techne into Merck's Life Science division

Merck KGaA of Darmstadt, Germany, agreed to buy Bio-Techne, a Minneapolis company that makes the reagents, proteins, and imaging tools researchers use at the lab bench. The price is $73 a share in cash, about $11.3 billion, a 36% premium over the recent trading average.

Updated 2 hours ago